Recombinant Human VEGF165 protein (His tag)

A DNA sequence encoding the Human VEGF165 protein (P15692) (Met1-Arg191) was expressed with a C-His.

Introducing the Recombinant Human Vascular Endothelial Growth Factor 165 Protein, a cutting-edge biotechnological advancement in the field of protein synthesis. This meticulously engineered protein, boasting a Histidine (HIS) tag, offers unparalleled efficacy and versatility in various scientific applications.

Derived from the human VEGF165 gene, this recombinant protein exhibits exceptional purity and stability, ensuring reliable and reproducible results in research and development endeavors. Its HIS tag facilitates facile purification and subsequent detection, enabling seamless integration into experimental protocols.

The Recombinant Human VEGF165 Protein (HIS TAG) showcases remarkable bioactivity, stimulating endothelial cell proliferation, migration, and angiogenesis. This property renders it an invaluable tool for investigating the intricate mechanisms underlying vascular development, wound healing, and tumor angiogenesis.

Furthermore, this protein's high affinity for VEGF receptors, particularly VEGFR-2, enhances its therapeutic potential in the realm of regenerative medicine. By promoting neovascularization, it holds promise for the treatment of ischemic diseases, such as myocardial infarction and peripheral arterial disease.

With its exceptional quality, purity, and functionality, the Recombinant Human VEGF165 Protein (HIS TAG) stands as an indispensable asset for researchers, clinicians, and biotechnologists alike. Unlock the potential of this groundbreaking protein and revolutionize your scientific pursuits with its unrivaled capabilities.